Narah Bate, 81, was recently diagnosed with a rare bone marrow cancer and given potentially life-prolonging drugs.But that didn’t go down too well with NICE, who decided the new drugs were just too expensive.
When she developed blisters in her throat and sores on her face, the professor treating her changed the prescription.
But medicine rationing body the National Institute for Health and Clinical Excellence (Nice) denied her the drug Imatinib saying it was too expensive and she would have to remain on hydroxycarbamide.Still, it’s a harsh world, and we all have to make sacrifices, and this way the NHS saves money to…
Audrey, 62, of Fleet, Hants, said: “The side-effects of this medication are so bad she had to stop taking it for a week to allow the blisters in her throat to heal. That meant a stay in hospital and a blood transfusion.Indeed.
“Now she’s having a blood transfusion almost every week. That takes up a hospital bed, using staff time. They say that Imatinib is too expensive, but treating her this way must cost more.”
What’s that old saying about those who know the price of everything and the value of nothing?